Hearing Changes After Intratympanically Applied Steroids for Primary Therapy of Sudden Hearing Loss: A Meta-analysis Using Mathematical Simulations of Drug Delivery Protocols
- PMID: 27779563
- PMCID: PMC5154844
- DOI: 10.1097/MAO.0000000000001254
Hearing Changes After Intratympanically Applied Steroids for Primary Therapy of Sudden Hearing Loss: A Meta-analysis Using Mathematical Simulations of Drug Delivery Protocols
Abstract
Objective: Controlled and uncontrolled studies with primary intratympanic or combined intratympanic and systemic application of glucocorticosteroids for idiopathic sudden hearing loss were analyzed by means of a meta-analysis in an attempt to establish optimal local drug delivery protocols.
Study design: A total of 25 studies with 28 treatment groups between January 2000 and June 2014 were selected that adequately described drug delivery protocols. Cochlear drug levels were calculated by a validated computer model of drug dispersion in the inner ear fluids based on the concentration and volume of glucocorticoids applied, the time the drug remained in the middle ear, and the specific timing of injections. Various factors were compared with hearing outcome, including baseline data, individual parameters of the application protocols, calculated peak concentration (Cmax), and total dose (area under the curve).
Results: There was no dependence of hearing outcome on individual parameters of the application protocol, Cmax, or area under the curve. Final hearing threshold was notably independent of delay of treatment.
Conclusion: During primary intratympanic or combined steroid therapy of idiopathic sudden hearing loss, the tendency toward early treatment having a positive effect on hearing improvement is thought to be a "sham effect," likely related to spontaneous recovery. Change in pure-tone average may not be an adequate outcome parameter to assess effectiveness of the intervention, as it depends on the degree of initial hearing loss. Final pure-tone average provides a better alternative.
Figures







Similar articles
-
Hearing Changes After Intratympanic Steroids for Secondary (Salvage) Therapy of Sudden Hearing Loss: A Meta-Analysis Using Mathematical Simulations of Drug Delivery Protocols.Otol Neurotol. 2018 Aug;39(7):803-815. doi: 10.1097/MAO.0000000000001872. Otol Neurotol. 2018. PMID: 29995001 Free PMC article.
-
Intratympanic steroids for treatment of sudden hearing loss after failure of intravenous therapy.Otolaryngol Head Neck Surg. 2007 Jul;137(1):74-8. doi: 10.1016/j.otohns.2007.01.022. Otolaryngol Head Neck Surg. 2007. PMID: 17599569 Clinical Trial.
-
Comparison of 2 and 4 Intratympanic Steroid Injections in the Treatment of Idiopathic Sudden Sensorineural Hearing Loss.Ann Otol Rhinol Laryngol. 2018 Apr;127(4):235-240. doi: 10.1177/0003489418755406. Epub 2018 Feb 7. Ann Otol Rhinol Laryngol. 2018. PMID: 29411622
-
Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.Laryngoscope. 2007 Jan;117(1):3-15. doi: 10.1097/01.mlg.0000245058.11866.15. Laryngoscope. 2007. PMID: 17202923 Review.
-
Primary treatment of idiopathic sudden sensorineural hearing loss with intratympanic dexamethasone.Curr Opin Otolaryngol Head Neck Surg. 2016 Oct;24(5):407-12. doi: 10.1097/MOO.0000000000000288. Curr Opin Otolaryngol Head Neck Surg. 2016. PMID: 27379547 Review.
Cited by
-
Impacts of different methylprednisolone administration routes in patients with sudden hearing loss or Meniere's disease.J Otol. 2020 Dec;15(4):149-154. doi: 10.1016/j.joto.2020.08.003. Epub 2020 Aug 22. J Otol. 2020. PMID: 33293916 Free PMC article.
-
Optimal timing of salvage intratympanic steroids in idiopathic sudden sensorineural hearing loss.Laryngoscope Investig Otolaryngol. 2022 Sep 14;7(5):1559-1567. doi: 10.1002/lio2.909. eCollection 2022 Oct. Laryngoscope Investig Otolaryngol. 2022. PMID: 36258873 Free PMC article.
-
Pharmacokinetic principles in the inner ear: Influence of drug properties on intratympanic applications.Hear Res. 2018 Oct;368:28-40. doi: 10.1016/j.heares.2018.03.002. Epub 2018 Mar 11. Hear Res. 2018. PMID: 29551306 Free PMC article. Review.
-
Intratympanic application of triamcinolone in sudden hearing loss-radiologic anatomy in cone beam CT and its' correlation to clinical outcome.Eur Arch Otorhinolaryngol. 2020 Jul;277(7):1931-1937. doi: 10.1007/s00405-020-05920-0. Epub 2020 Mar 23. Eur Arch Otorhinolaryngol. 2020. PMID: 32206871 Free PMC article.
-
[The HODOKORT trial and current aspects of treatment of idiopathic sudden sensorineural hearing loss with glucocorticoids].HNO. 2024 Jun;72(6):389-392. doi: 10.1007/s00106-024-01458-3. Epub 2024 Apr 10. HNO. 2024. PMID: 38600226 Free PMC article. German. No abstract available.
References
-
- Vlastarakos PV, Papacharalampous G, Maragoudakis P, et al. Are intra-tympanically administered steroids effective in patients with sudden deafness? Implications for current clinical practice. Eur Arch Otorhinolaryngol. 2012;269:363–80. - PubMed
-
- Lavigne P, Lavigne F, Saliba I. Intratympanic corticosteroids injections: a systematic review of literature. Eur Arch Otorhinolaryngol. 2015 - PubMed
-
- Huon LK, Fang TY, Wang PC. Outcomes of intratympanic gentamicin injection to treat Meniere's disease. Otol Neurotol. 2012;33:706–14. - PubMed
-
- Stachler RJ, Chandrasekhar SS, Archer SM, et al. Clinical practice guideline: sudden hearing loss. Otolaryngol Head Neck Surg. 2012;146:S1–35. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical